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We report a 63,584-bp conjugative IncL plasmid (pUR17313-1) from an Enterobacter cloacae clinical isolate, containing a
blaOXA-48 gene. The plasmid sequence also carried important mobile genetic elements involved in the spread of antibiotic resis-
tance, namely, the Tn1999.2 composite transposon, which enclosed blaOXA-48-, integrase-, and transposase-encoding genes.
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Bacterial plasmids are key vectors of horizontal gene transfer,mediating the mobilization of genetic material among bacte-
ria (1). This study aimed to characterize an IncL/M-like plasmid
containing a blaOXA-48 gene from an Enterobacter cloacae clinical
isolate, which constituted the first case of OXA-48-producing En-
terobacteriaceae in Portugal (2).
PlasmidDNAwasextractedfromthetransconjugantTc17313-1(2),
using a NucleoBond Xtra Plus kit (Macherey-Nagel) according to
the manufacturer’s instructions. Plasmid-Safe ATP-Dependent
DNase (Epicentre) was used to eliminate any contamination with
chromosomal DNA. The molecular size of the OXA-48-carrying
plasmid was estimated by using a GeneRuler High Range DNA
Ladder (Thermo Scientific). Five hundred nanograms of the plas-
mid DNA were fragmented by nebulization, followed by adaptor
ligation to create double-stranded DNA libraries and pyrose-
quenced in GS FLX (454 Roche-Life Sciences), with Titanium
chemistry, according to the manufacturer’s standard protocols.
The sequencing with the 454 pyrosequencer produced 174,217
reads with an average length of 464 bases. Sequencing reads were
assembled with the GS Assembler version 2.8 (Roche) into 19
contigs, the largest being 40,523 bp long.
Analysis of the coverage indicated the presence of 5 contigs
with more than 1,000-fold coverage, while the remaining 14 cor-
responded to small-length consensus sequenceswith residual cov-
erage (2.7- to 8.8-fold). The ResFinder version 2.1 tool (3) was
used to detect the blaOXA-48 gene in the pUR17313-1 plasmid; no
other acquired antimicrobial resistance gene was found.
The submission of the 5 contigs to BLASTn (http://blast.ncbi
.nlm.nih.gov) enabled the identification of the closest plasmid se-
quences. Final annotation of the plasmid was performed with the
NCBI Prokaryotic Genome Annotation Pipeline (http://www
.ncbi.nlm.nih.gov/genome/annotation_prok). The BLASTn
search identified that contigs were highly similar to the Klebsiella
pneumoniae blaOXA-48-encoding pOXA-48 (JN626286), E71T
(KC335143), pKPoxa-48N1 (NC_021488), pKPoxa-48N2 (NC_
021502), and pKpn-E1.Nr7 (KM406491) plasmid sequences,
detected in Turkey (4), France (5), Ireland (6), and Switzerland
(7). Therefore, the pUR17313-1 plasmid structure was con-
structed based on the genetic organization of those plasmids,
and the contig neighbors predicted from contig assembly in-
formation.
Overall, plasmid pUR17313-1 was 63,584 bp in length with a
GC content of 51.2%. The presence of a Tra region revealed that
the plasmid was conjugative. The blaOXA-48 gene was enclosed on
a Tn1999.2 composite transposon. Although this plasmid was not
typeable by PCR-based replicon typing (2, 4), the incRNA se-
quence revealed that pUR17313-1 was an IncL (7). In addition,
PHAST analysis predicted one putative incomplete prophage re-
gion, from position 3,856 to 17,385 (13,530 bp), consisting of 28
putative coding sequences, including procapsid-like particles and
integrase- and transposase-encoding genes, with a 4.32% GC
content (8).
We confirmed that the blaOXA-48 gene was carried by the wide-
spread 63-kb conjugative IncL plasmid, which did not encode
additional resistance markers but contained other important
mobile genetic elements involved in the spread of antibiotic
resistance. Given the clinical and epidemiological relevance of
these plasmids, its complete sequence is important to under-
stand plasmid evolution and differentiation. In the end, the
availability of complete plasmid sequences from different
countries supports the global epidemiological surveillance of
antibiotic resistance spread.
Nucleotide sequence accession number. The genome se-
quence of pUR17313-1 has been submitted to GenBank under the
accession number KP061858.
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